SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for DIGIRAD CORP (STRR, STRRP) (CIK 0000707388) — Jun 23, 2022

DIGIRAD CORP (STRR, STRRP) (CIK 0000707388)
Date: June 23, 2022 · CIK: 0000707388 · Accession: 0000000000-22-006790

AI Filing Summary & Sentiment

File numbers found in text: 333-265737

Date
June 23, 2022
Author
Not clearly detected
Form
UPLOAD
Company
DIGIRAD CORP (STRR, STRRP) (CIK 0000707388)

Letter

United States securities and exchange commission logo June 23, 2022 Richard K. Coleman, Jr. Chief Executive Officer Star Equity Holdings, Inc. 53 Forest Ave., Suite 101 Old Greenwich, CT 06870 Re:Star Equity Holdings, Inc. Registration Statement on Form S-3 Filed June 21, 2022 File No. 333-265737 Dear Mr. Coleman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Claudia B. Dubón, Esq.

Show Raw Text
United States securities and exchange commission logo
June 23, 2022
Richard K. Coleman, Jr.
Chief Executive Officer
Star Equity Holdings, Inc.
53 Forest Ave., Suite 101
Old Greenwich, CT 06870
Re:Star Equity Holdings, Inc.
Registration Statement on Form S-3
Filed June 21, 2022
File No. 333-265737
Dear Mr. Coleman:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Claudia B. Dubón, Esq.